SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Deferred Tax Liabilities

Taxes owed in future periods because of timing differences between accounting and tax rules.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Deferred Tax Liabilities · Q1 FY2026 · quarter ended Mar 2026

Deferred tax liabilities of $0 in Q1 FY2026

Q1 FY2026 deferred tax liabilities was $0.

Context

  • Deferred tax liabilities amounted to 0.0% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Deferred Tax Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Tax Liabilities history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Deferred Tax Liabilities vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred tax liabilities is compared through growth and share of total assets rather than absolute size.
  • Deferred tax liabilities amounts to 0.0% of total assets for SGP, versus a peer median of 0.0%.
SGP Competitors
Deferred Tax Liabilities for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$848M USD-6.8%—2.7%
BLCOBausch + Lomb CorporationJun 2026$18M USD+28.6%+39.5%0.1%
GKOSGlaukos CorporationJun 2026$441K USD-93.6%-82.3%0.0%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$0 USD——0.0%
OCULOcular Therapeutix, Inc.Mar 2026$0 USD——0.0%
STAASTAAR Surgical CompanyApr 2026$0 USD—+88.3%0.0%
SGHTSight Sciences, Inc.Mar 2026$0 USD——0.0%
OCSOculis Holding AGMar 2026CHF 0 CHF——0.0%
RXSTRxSight, Inc.Mar 2026$0 USD——0.0%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding SGP) —-6.8%+39.5%0.0%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.